Jun Li

机构：Kunming University of Science and Technology, Qingdao University, Affiliated Hospital of Qingdao University, Jiangsu Cancer Hospital, Guangdong Academy of Medical Sciences · ORCID：0009-0008-5528-4705

发表论文 338 篇 · 总被引 6904 次 · h-index 42

代表论文

• Total neoadjuvant treatment with short-course radiotherapy followed by sintilimab plus capecitabine–oxaliplatin versus short-course radiotherapy followed by capecitabine–oxaliplatin in patients with locally advanced rectal cancer (SPRING-01): a single-centre, open-label, phase 2, randomised controlled trial (2025 · The Lancet Oncology · 被引 34)
• Deep-learning-based HER2 status assessment from multimodal breast cancer data predicts neoadjuvant therapy response (2025 · Nature Biomedical Engineering · 被引 10)
• Benign non-immune cells in tumor microenvironment (2025 · Frontiers in Immunology · 被引 9)
• Global clinical trial landscape and therapeutic trends in bladder cancer: a systematic analysis (2025 · International Journal of Surgery · 被引 7)
• Germination duration modulates wheat composition, metabolic reprogramming, and processing functionality: Insights from metabolome and rheological profiling (2025 · LWT · 被引 3)
• NLRP3 targets HMGB1 to exacerbate the pyroptosis of canine corneal epithelial cells infected with Staphylococcus pseudintermedius (2024 · Experimental Eye Research · 被引 3)